comparemela.com

Latest Breaking News On - Sarah crafton - Page 1 : comparemela.com

Dr Crafton on the Use of Mirvetuximab Soravtansine in Ovarian Cancer

Sarah Crafton, MD, discusses the potential future of antibody-drug conjugates in patients with ovarian cancer.

Dr Crafton on the Impact of Mirvetuximab Soravtansine on Clinical Practice in Ovarian Cancer

Sarah Crafton, MD, discusses the integration of mirvetuximab soravtansine-gynx into clinical practice in the treatment of ovarian cancer.

Ongoing ADC Development Continues to Gain Traction in Ovarian Cancer

Sarah Crafton, MD, discusses the ongoing development of agents targeting key biomarkers in ovarian cancer, such as FRĪ± and HER2; expands on the integration of mirvetuximab soravtansine into clinical practice and its investigation in earlier lines; and emphasizes the importance of continued patient enrollment onto ongoing or planned ADC trials in ovarian cancer.

Allegheny Health Network oncology experts delve into the latest information in the field of gynecologic oncology

Allegheny Health Network oncology experts delve into the latest information in the field of gynecologic oncology
independantexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from independantexpress.com Daily Mail and Mail on Sunday newspapers.

Allegheny Health Network Oncology Experts Dive Into Updates Within the Gynecologic Oncology Space

Eirwen M. Miller, MD, spotlights updated data within the endometrial, cervical, and ovarian cancer spaces following the ESMO Congress 2023 and the 2023 ASCO Annual Meeting, focusing on how these updates continue to shift clinical practice and advance care.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.